These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 22849291)

  • 21. Hydrophobic drug concentration affects the acoustic susceptibility of liposomes.
    Nguyen AT; Lewin PA; Wrenn SP
    Biochim Biophys Acta; 2015 Apr; 1850(4):667-72. PubMed ID: 25450487
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Liposomes as a Promising Ultrasound-Triggered Drug Delivery System in Cancer Treatment.
    Salkho NM; Turki RZ; Guessoum O; Martins AM; Vitor RF; Husseini GA
    Curr Mol Med; 2017; 17(10):668-688. PubMed ID: 29663885
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A targeting drug-delivery model via interactions among cells and liposomes under ultrasonic excitation.
    Xi X; Yang F; Chen D; Luo Y; Zhang D; Gu N; Wu J
    Phys Med Biol; 2008 Jun; 53(12):3251-65. PubMed ID: 18506075
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ultrasound-mediated drug delivery using liposomes modified with a thermosensitive polymer.
    Ninomiya K; Kawabata S; Tashita H; Shimizu N
    Ultrason Sonochem; 2014 Jan; 21(1):310-6. PubMed ID: 23948493
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of inherently echogenic liposomes as an ultrasonic contrast agent.
    Alkan-Onyuksel H; Demos SM; Lanza GM; Vonesh MJ; Klegerman ME; Kane BJ; Kuszak J; McPherson DD
    J Pharm Sci; 1996 May; 85(5):486-90. PubMed ID: 8742939
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lipid-shelled vehicles: engineering for ultrasound molecular imaging and drug delivery.
    Ferrara KW; Borden MA; Zhang H
    Acc Chem Res; 2009 Jul; 42(7):881-92. PubMed ID: 19552457
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Loss of gas from echogenic liposomes exposed to pulsed ultrasound.
    Raymond JL; Luan Y; Peng T; Huang SL; McPherson DD; Versluis M; de Jong N; Holland CK
    Phys Med Biol; 2016 Dec; 61(23):8321-8339. PubMed ID: 27811382
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ultrasonically controlled albumin-conjugated liposomes for breast cancer therapy.
    Awad NS; Paul V; Al-Sayah MH; Husseini GA
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):705-714. PubMed ID: 30873869
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A mathematical model of drug release from liposomes by low frequency ultrasound.
    Enden G; Schroeder A
    Ann Biomed Eng; 2009 Dec; 37(12):2640-5. PubMed ID: 19731036
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acoustic characterization of echogenic liposomes: frequency-dependent attenuation and backscatter.
    Kopechek JA; Haworth KJ; Raymond JL; Douglas Mast T; Perrin SR; Klegerman ME; Huang S; Porter TM; McPherson DD; Holland CK
    J Acoust Soc Am; 2011 Nov; 130(5):3472-81. PubMed ID: 22088022
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The use of ultrasound to release chemotherapeutic drugs from micelles and liposomes.
    Ahmed SE; Martins AM; Husseini GA
    J Drug Target; 2015 Jan; 23(1):16-42. PubMed ID: 25203857
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A novel drug vehicle capable of ultrasound-triggered release with MRI functions.
    Liu TY; Huang TC
    Acta Biomater; 2011 Nov; 7(11):3927-34. PubMed ID: 21745611
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular Study of Ultrasound-Triggered Release of Fluorescein from Liposomes.
    El Hajj F; Fuchs PFJ; Urbach W; Nassereddine M; Hamieh S; Taulier N
    Langmuir; 2021 Apr; 37(13):3868-3881. PubMed ID: 33769822
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Destruction thresholds of echogenic liposomes with clinical diagnostic ultrasound.
    Smith DA; Porter TM; Martinez J; Huang S; MacDonald RC; McPherson DD; Holland CK
    Ultrasound Med Biol; 2007 May; 33(5):797-809. PubMed ID: 17412486
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improving ultrasound reflectivity and stability of echogenic liposomal dispersions for use as targeted ultrasound contrast agents.
    Huang SL; Hamilton AJ; Nagaraj A; Tiukinhoy SD; Klegerman ME; McPherson DD; Macdonald RC
    J Pharm Sci; 2001 Dec; 90(12):1917-26. PubMed ID: 11745750
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vivo monitoring of liposomal release in tumours following ultrasound stimulation.
    Evjen TJ; Hagtvet E; Moussatov A; Røgnvaldsson S; Mestas JL; Fowler RA; Lafon C; Nilssen EA
    Eur J Pharm Biopharm; 2013 Aug; 84(3):526-31. PubMed ID: 23274944
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ultrasound-mediated delivery of echogenic immunoliposomes to porcine vascular smooth muscle cells in vivo.
    Laing ST; Kim H; Kopechek JA; Parikh D; Huang S; Klegerman ME; Holland CK; McPherson DD
    J Liposome Res; 2010 Jun; 20(2):160-7. PubMed ID: 19842795
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ultrasound-enhanced thrombolysis with tPA-loaded echogenic liposomes.
    Shaw GJ; Meunier JM; Huang SL; Lindsell CJ; McPherson DD; Holland CK
    Thromb Res; 2009 Jul; 124(3):306-10. PubMed ID: 19217651
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Motion Compensated Ultrasound Imaging Allows Thermometry and Image Guided Drug Delivery Monitoring from Echogenic Liposomes.
    Ektate K; Kapoor A; Maples D; Tuysuzoglu A; VanOsdol J; Ramasami S; Ranjan A
    Theranostics; 2016; 6(11):1963-74. PubMed ID: 27570563
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ultrasound-sensitive cRGD-modified liposomes as a novel drug delivery system.
    AlSawaftah NM; Paul V; Kosaji D; Khabbaz L; Awad NS; Husseini GA
    Artif Cells Nanomed Biotechnol; 2022 Dec; 50(1):111-120. PubMed ID: 35543613
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.